Literature DB >> 32880013

Use of the MMPI-2 personality profile in predicting 30-day ED-visits and readmissions following primary bariatric surgery.

Jennwood Chen1, Anahita Jalilvand1, Mahmoud Abdel-Rasoul2, Kayla Diaz1, Lindsay Breslin1, Vivian L Wang1, Bradley Needleman1, Sabrena F Noria3.   

Abstract

BACKGROUND: Minnesota Multiphasic Personality Inventory-2 (MMPI-2) is used for psychological screening of bariatric surgery (BS) candidates. To date, no studies have analyzed the relationship between MMPI-2 and early returns to hospital. The aim of this study was to determine whether high T scores on the MMPI-2 clinical scales were associated with early return to hospital after primary bariatric surgery.
METHODS: Patients who completed an MMPI-2 evaluation, undergoing primary BS from 2014 to 2016 were evaluated. T score for the tested scales were collected and stratified into a high T score (T > 65) vs not (T < 65). The optimal 'cut-point' (specific number of high T scores predicting likelihood for 30-day ED-visit/hospital readmission) was calculated using Youden's Index (J) = Max(c) [sensitivity (c) + specificity (c) - 1], where c = number of scales with a T score > 65. Patients were stratified based on the optimal cut-point which was determined to be ≥ 4 high T scores. Univariate and multivariate logistic regression analyses were used to identify differences between groups and predictors for early ED-visits and hospital readmissions.
RESULTS: 375 patients had psychological evaluations available for review. Patients were divided into those with ≥ 4 high T scores (Scr(≥4); n = 86) versus not (Scr (<4); n = 289). Multivariate analysis showed Scr(≥ 4) (aOR 2.99, CI 1.20-7.47; p = 0.019), bipolar disorder (aOR 4.82, CI 1.25-18.83; p = 0.022), and urgent hospital complications (aOR 6.81, CI 2.02-22.91; p = 0.002), were significant independent predictors of 30-day readmissions. Early ED-visits were significantly predicted by public insurance (aOR 3.30, CI 1.22-8.91; p = 0.019), but the effect of the Scr(≥4) profile (aOR 2.42, CI 0.97-6.09; p = 0.06), while influential, did not reach significance.
CONCLUSION: Differences in personality traits may be associated increased 30-day readmissions following primary bariatric surgery. Our study represents a novel application of the MMPI-2.

Entities:  

Keywords:  Bariatric surgery; Early readmission; Emergency department visit; MMPI-2

Year:  2020        PMID: 32880013     DOI: 10.1007/s00464-020-07944-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  40 in total

1.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

2.  Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data.

Authors:  Robert T Lancaster; Matthew M Hutter
Journal:  Surg Endosc       Date:  2008-09-20       Impact factor: 4.584

3.  Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.

Authors:  Donald C Simonson; Florencia Halperin; Kathleen Foster; Ashley Vernon; Allison B Goldfine
Journal:  Diabetes Care       Date:  2018-02-06       Impact factor: 19.112

4.  Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial.

Authors:  Anita P Courcoulas; James W Gallagher; Rebecca H Neiberg; Emily B Eagleton; James P DeLany; Wei Lang; Suriya Punchai; William Gourash; John M Jakicic
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

5.  Predicting potentially preventable hospital readmissions following bariatric surgery.

Authors:  Wendy L Patterson; Brittany D Peoples; Foster C Gesten
Journal:  Surg Obes Relat Dis       Date:  2014-12-24       Impact factor: 4.734

6.  Factors associated with readmission after laparoscopic gastric bypass surgery.

Authors:  Brian Hong; Edwin Stanley; Susan Reinhardt; Kristen Panther; Michael J Garren; Jon C Gould
Journal:  Surg Obes Relat Dis       Date:  2011-06-15       Impact factor: 4.734

7.  One-Year Mortality after Contemporary Laparoscopic Bariatric Surgery: An Analysis of the Bariatric Outcomes Longitudinal Database.

Authors:  Colette S Inaba; Christina Y Koh; Sarath Sujatha-Bhaskar; Jack P Silva; Yanjun Chen; Danh V Nguyen; Ninh T Nguyen
Journal:  J Am Coll Surg       Date:  2018-03-16       Impact factor: 6.113

8.  Emergency room visits after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  Minyoung Cho; Orit Kaidar-Person; Samuel Szomstein; Raul J Rosenthal
Journal:  Surg Obes Relat Dis       Date:  2007-11-05       Impact factor: 4.734

Review 9.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22

10.  Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.

Authors:  Emanuele Di Angelantonio; Shilpa Bhupathiraju; David Wormser; Pei Gao; Stephen Kaptoge; Amy Berrington de Gonzalez; Benjamin Cairns; Rachel Huxley; Chandra Jackson; Grace Joshy; Sarah Lewington; JoAnn Manson; Neil Murphy; Alpa Patel; Jonathan Samet; Mark Woodward; Wei Zheng; Maigen Zhou; Narinder Bansal; Aurelio Barricarte; Brian Carter; James Cerhan; George Smith; Xianghua Fang; Oscar Franco; Jane Green; Jim Halsey; Janet Hildebrand; Keum Jung; Rosemary Korda; Dale McLerran; Steven Moore; Linda O'Keeffe; Ellie Paige; Anna Ramond; Gillian Reeves; Betsy Rolland; Carlotta Sacerdote; Naveed Sattar; Eleni Sofianopoulou; June Stevens; Michael Thun; Hirotsugu Ueshima; Ling Yang; Young Yun; Peter Willeit; Emily Banks; Valerie Beral; Zhengming Chen; Susan Gapstur; Marc Gunter; Patricia Hartge; Sun Jee; Tai-Hing Lam; Richard Peto; John Potter; Walter Willett; Simon Thompson; John Danesh; Frank Hu
Journal:  Lancet       Date:  2016-07-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.